Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Wu Sheng-Jiun is active.

Publication


Featured researches published by Wu Sheng-Jiun.


Archive | 2017

ANTAGONISTI DEL RECETTORE 3 DI TIPO TOLL

Cunningham Mark; San Mateo Lani; Sweet Raymond; Rauchenberger Robert; Rutz Mark; Feng Yiqing; Heeringa Katharine; Luo Jinquan; Teng Fang; Teplyakov Alexey; Wu Sheng-Jiun; Sarisky Robert T


Archive | 2017

AGENTES DE UNIÓN A CD123 Y USOS DE ESTOS

Attar Ricardo; Harman Benjamin C; Gaudet Francois; Luo Jinquan; Li Yingzhe; Tam Susan H; Teplyakov Alexey; Wheeler Jhon; Wu Sheng-Jiun; Nemeth Jennifer F; Mcdaid Ronan; Pomerantz Steven C


Archive | 2017

ΑΝΤΑΓΩΝΙΣΤΕΣ ΤΟΥ ΥΠΟΔΟΧΕΑ 3 ΤΥΠΟΥ TOLL

Cunningham Mark; Feng Yiqing; Heeringa Katharine; Luo Jinquan; Rauchenberger Robert; Rutz Mark; San Mateo Lani; Sarisky Robert T; Sweet Raymond; Teng Fang; Teplyakov Alexey; Wu Sheng-Jiun


Archive | 2017

ΑΝΤΑΓΩΝΙΣΤΕΣ TOLL-ΩΔΟΥΣ ΥΠΟΔΟΧΕΑ 3

Cunningham Mark; San Mateo Lani; Sarisky Robert T; Sweet Raymond; Rauchenberger Robert; Rutz Mark; Feng Yiqing; Heeringa Katharine; Luo Jinquan; Teng Fang; Teplyakov Alexey; Wu Sheng-Jiun


Archive | 2017

ANTI-ROR1, ANTIBODIES, ROR1 X CD3 BISPECIFIC ANTIBODIES, AND METHODS OF USING THE SAME

Anderson Glenn Mark; Attar Ricardo; Baldwin Eric T; Cardoso Rosa M F; Gaudet Francois; Harman Benjamin; Li Yingzhe; Luo Jinquan; Mcdaid Ronan; Nemeth-Seay Jennifer F; Pomerantz Steven C; Teplyakov Alexey; Tam Susan H; Wu Sheng-Jiun


Archive | 2016

ST2L ANTAGONISTS AND METHODS OF USE ST2L

Duffy Karen; Healy Catherine; Lamb Roberta; Malaviya Ravi; Pratta Michael; Fursov Natalie; Luo Jinquan; Naso Michael; Tornetta Mark; Wheeler John; Wu Sheng-Jiun; Hall Leroy


Archive | 2016

ANTAGONISTI DEL RECETTORE TOLL-LIKE 3

Cunningham Mark; San Mateo Lani; Sarisky Robert T; Sweet Raymond W; Rauchenberger Robert; Rutz Mark; Feng Yiqing; Heeringa Katharine; Luo Jinquan; Teng Fang; Teplyakov Alexey; Wu Sheng-Jiun


Archive | 2016

ISOLATED ANTIBODY REACTIVE WITH TLR3

Cunningham Mark; San Mateo Lani; Sarisky Robert T; Sweet Raymond; Rauchenberger Robert; Rutz Mark; Feng Yiqing; Heeringa Katharine; Luo Jinquan; Teng Fang; Teplyakov Alexey; Wu Sheng-Jiun


Archive | 2016

anticorpo de fator de tecidos humanos e usos do mesmo

Teplyakov Alexey; Martinez Christian; Chi Ellen; Anderson Glenn Mark; Raghunathan Gopalan; Zhou Hong Mimi; Almargo Juan Carlos; Tse Kam-Fai; Swanson Ronald; Wu Sheng-Jiun


Archive | 2016

TOLL-LIKE RECEPTOR 3 ANTAGONISTS TOLL 3

Cunningham Mark; Feng Yiqing; Heeringa Katharine; Luo Jinquan; Rauchenberger Robert; Rutz Mark; San Mateo Lani; Sarisky Robert; Sweet Raymond; Teng Fang; Teplyakov Alexey; Wu Sheng-Jiun

Collaboration


Dive into the Wu Sheng-Jiun's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Teng Fang

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge